Breast cancer
Results
Phase 3
This trial was trying to find out if 2 drugs called exemestane and celecoxib could help to treat ductal carcinoma in situ.
Recruitment start: 1 September 2003
Recruitment end: 31 December 2006
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Nigel Bundred
Celecoxib Oncology Research in Europe (CORE)
National Institute for Health Research Cancer Research Network (NCRN)
University Hospital of South Manchester (UHSM)
University of Manchester
Last reviewed: 02 Nov 2012
CRUK internal database number: 569
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
